CPMV
Price:
$0.819
Market Cap:
$5.43M
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.[Read more]
Industry
Biotechnology
IPO Date
2013-01-02
Stock Exchange
PNK
Ticker
CPMV
According to Mosaic ImmunoEngineering Inc.’s latest financial reports and current stock price. The company's current ROE is 5.79%. This represents a change of -3.91% compared to the average of 6.02% of the last 4 quarters.
The mean historical ROE of Mosaic ImmunoEngineering Inc. over the last ten years is 1.01%. The current 5.79% ROE has changed 472.17% with respect to the historical average. Over the past ten years (40 quarters), CPMV's ROE was at its highest in in the November 2020 quarter at 169.21%. The ROE was at its lowest in in the November 2019 quarter at -61.07%.
Average
1.01%
Median
-11.88%
Minimum
-48.47%
Maximum
131.63%
Discovering the peaks and valleys of Mosaic ImmunoEngineering Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 131.63%
Minimum Annual Increase = -267.23%
Minimum Annual ROE = -48.47%
Year | ROE | Change |
---|---|---|
2022 | 48.74% | -62.97% |
2021 | 131.63% | Infinity% |
2020 | 0% | -100.00% |
2020 | -47.06% | -2.91% |
2018 | -48.47% | 3.86% |
2017 | -1.22% | -96.37% |
2016 | -33.78% | 10.17% |
2015 | -30.66% | 36.10% |
2014 | -22.53% | -267.23% |
2013 | 13.47% | -119.82% |
The current ROE of Mosaic ImmunoEngineering Inc. (CPMV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
60.13%
5-year avg
16.97%
10-year avg
1.01%
Mosaic ImmunoEngineering Inc.’s ROE is less than Cell Source, Inc. (31.36%), less than Marizyme, Inc. (448.62%), less than Emmaus Life Sciences, Inc. (10.80%), greater than Acro Biomedical Co., Ltd. (-2808.91%), greater than Ceapro Inc. (-21.67%),
Company | ROE | Market cap |
---|---|---|
31.36% | $25.16M | |
448.62% | $5.27M | |
10.80% | $1.92M | |
-2808.91% | $60.04K | |
-21.67% | $13.31M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mosaic ImmunoEngineering Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mosaic ImmunoEngineering Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Mosaic ImmunoEngineering Inc.'s ROE?
How is the ROE calculated for Mosaic ImmunoEngineering Inc. (CPMV)?
What is the highest ROE for Mosaic ImmunoEngineering Inc. (CPMV)?
What is the 3-year average ROE for Mosaic ImmunoEngineering Inc. (CPMV)?
What is the 5-year average ROE for Mosaic ImmunoEngineering Inc. (CPMV)?
How does the current ROE for Mosaic ImmunoEngineering Inc. (CPMV) compare to its historical average?